Yes-associated Protein Promotes Early Hepatocyte Cell Cycle Progression in Regenerating Liver after Tissue Loss.

Christoph Tschuor,Ekaterina Kachaylo,Udo Ungethuem,Zhuolun Song,Kuno Lehmann,Patricia Sanchez-Velazquez,Michael Linecker,Patryk Kambakamba,Dimitri A. Raptis,Perparim Limani,Dilmurodjon Eshmuminov,Rolf Graf,Amedeo Columbano,Bostjan Humar,Pierre-Alain Clavien

DOI: https://doi.org/10.1096/fba.1023

2018-01-01

FASEB BioAdvances

Abstract:The ability of the liver to restore its original volume following tissue loss has been associated with the Hippo-YAP1 pathway, a key controller of organ size. Yes-associated protein 1 (YAP1)-a growth effector usually restrained by Hippo signalingis believed to be of particular importance; however, its role in liver regeneration remains ill-defined. To explore its function, we knocked down YAP1 prior to standard 70%-hepatectomy (sHx) using a hepatocyte-specific nanoformulation. Knockdown was effective during the major parenchymal growth phase (S-phase/Mphase peaks at 32 hours/48 hours post-sHx). Liver weight gain was completely suppressed by the knockdown at 32 hours, but was reaccelerated toward 48 hours. Likewise, proliferative markers, Ccna2/b2 and YAP1 target gene expression were downregulated at 32 hours, but re-elevated at 48 hours post-sHx. Nonetheless, knockdown slightly compromised survival after sHx. When assessing a model of resection-induced liver failure (extended 86%-hepatectomy, eHx) featuring deficient S- and M-phase progression, YAP1 was not induced at 32 hours, but upregulated at 48 hours post-eHx, confirming its dissociation from M-phase regulation. Therefore, YAP1 is vital to push hepatocytes into cycle and through the S-phase, but is not required for further cell cycle progression during liver regeneration. The examination of YAP1 in human livers suggested its function is conserved in the regenerating mammalian liver.